Feedback / Questions
TPI 287 - CNS Pharma
berubicin (RTA 744) - CNS Pharma, WPD Pharma
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cns-pharmaceuticals-announces-acceptance-of-three-abstracts-for-poste-1098602
Nov 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next